Kontracept

Ethinylestradiol and Gestodene, the active ingredients in Kontracept, are a combined estrogen‑progestogen presented as a tablet for oral use. They prevent pregnancy in women of childbearing age.

GNH USA supplies Kontracept as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kontracept, a combined estrogen‑progestogen oral contraceptive, is indicated for hormonal contraception.

- Prevention of pregnancy: provides reliable contraceptive protection for women of reproductive potential. - Regulation of menstrual cycle: helps achieve more regular bleeding patterns and reduces menstrual discomfort. - Treatment of acne: can improve mild to moderate acne associated with hormonal fluctuations.

Common Side Effects: - Nausea or mild gastrointestinal upset. - Breast tenderness or enlargement. - Headache or migraine. - Spotting or breakthrough bleeding. - Weight gain or fluid retention. - Mood changes or irritability.

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism). - Arterial thrombosis (stroke, myocardial infarction). - Severe hypertension. - Hepatic adenoma or other liver tumours. - Anaphylactic or severe allergic reactions.

Kontracept should be used only after a thorough medical assessment.

- Contraindications: known thromboembolic disease, pregnancy, estrogen‑dependent tumours, severe liver dysfunction. - Smoking: avoid use in women over 35 who smoke due to increased cardiovascular risk. - Cardiovascular risk: assess blood pressure and lipid profile before initiation. - Drug interactions: review concomitant medications that may alter hormone levels. - Monitoring: schedule periodic evaluation of blood pressure and any signs of thrombosis. - Store at ambient temperature: keep tablets below 25 °C in the original container, protected from moisture and light.

Kontracept may interact with several medicines that affect hormone metabolism.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin) can markedly reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin) may have altered anticoagulant effect, requiring closer INR monitoring. - Certain antiretrovirals (e.g., efavirenz) can diminish hormone levels and increase pregnancy risk.

Moderate Interactions (Monitor Closely): - SSRIs and other antidepressants may increase bleeding tendency. - Azole antifungals (e.g., ketoconazole) can raise plasma hormone concentrations, potentially increasing side‑effect risk. - Herbal supplements such as St. John’s wort may lower contraceptive effectiveness. - Antibiotics (e.g., clarithromycin) may modestly affect hormone levels. - Anticonvulsants with moderate enzyme induction (e.g., phenobarbital) require monitoring of contraceptive reliability.